Back to top

Novo Nordisk (NVO) Enters Oversold Territory
March 06, 2014

Read MoreHide Full Article
Novo Nordisk A/S ’s (NVO - Free Report) share price has entered into oversold territory with an RSI value of 21.9. The Zacks Consensus Estimate for Novo Nordisk for the full year period has improved 75 cents over the past two months to $1.90 per share. Currently, Novo Nordisk has a Zacks Rank #2 (Buy), suggesting that now might be a good time to get in on (NVO - Free Report) after its recent drop.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novo Nordisk A/S (NVO) - free report >>

More from Zacks Tale of the Tape

You May Like